Their study size is only half the size of what OB did with their...

Their study size is only half the size of what OB did with their study - which was about 900 and something participants. So my view is that IIQ’s is fairly small and won’t be sufficient. And it looks like in the lab it’s not going to be a standard test with equipment but something a little more complex? Not entirely sure though. So I reckon even if they find a partner to run with it as OB was trying to, they would still be running a bigger trial to get the data they really need for further approval in the US. Should be really interesting to see what difference DW makes compared to OB.

My reading is that OB’s expansion program is still happening but no where near as advanced as here with these guys. I agree this is more organised and could result in success. OB has got a lot of the tedious work for the expansion program outsourced so it will speed things up. With both of these companies it’s really difficult to gauge a timeframe for commercialisation though. I wonder if talks are already underway and if parties are interested or is it all at very early stages… Hope communication from here on is frequent regarding updates so we get a view of how far along things are.

interested in your views on any of this.